Not finding it? Sign in to also search OpenAlex live.
-
Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up2022 European Journal Of Haematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Natascha A. Møller‐Palacino, Rasmus Kristoffer Pedersen, Morten Andersen, +14 more
18citations -
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study2026 Blood Advances article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Harinder Gill, Abdulraheem Yacoub, Aaron Thomas Gerds, Jake Shortt, James M. Rossetti, Adam J. Mead, +16 more
2citations -
Abstract LB134: Type 1 calreticulin mutations differentially activate the IRE1α-XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms2022 Cancer Research conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Juan Ibarra, Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo, Harrison S. Greenbaum, Nicole Arellano, +19 more
0citations -
Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
0citations -
Safety and efficacy of the mutant calreticulin-specific monoclonal antibody INCA033989 as monotherapy or in combination with ruxolitinib in patients (pts) with myelofibrosis (MF): Preliminary results from dose escalation of two global Phase 1 studies
Andrew Charles Perkins, Vincent Ribrag, William E. Shomali, Rosa María Ayala, Claire N. Harrison, Stephen T. Oh, +2 more
14citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
MPN-481: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Haris Ali, Tania Jain, Aaron Thomas Gerds, Vikas Gupta, Claire N. Harrison, Joan How, +27 more
0citations -
POSTER: MPN-556: Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
John O Mascarenhas, Jyoti Nangalia, Claire N. Harrison, Jason R. Gotlib, Chenwei Tian, Betty Lamothe, +4 more
0citations -
POSTER: MPN-554: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Tania Jain, Vikas Gupta, Haifa Kathrin Al‐Ali, Haris Ali, John O Mascarenhas, Francesco Passamonti, +22 more
0citations -
POSTER: MPN-481: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Haris Ali, Tania Jain, Aaron Thomas Gerds, Vikas Gupta, Claire N. Harrison, Joan How, +27 more
0citations -
MPN-556: Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
John O Mascarenhas, Jyoti Nangalia, Claire N. Harrison, Jason R. Gotlib, Chenwei Tian, Betty Lamothe, +4 more
0citations -
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms2024 Scientific Reports article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kristin Holl, Nicolas Chatain, Susanne Krapp, Julian Baumeister, Tiago Maié, Sarah M. Schmitz, +4 more
8citations -
Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms2022 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Milena Kalmer, Kristina Pannen, Rebecca Lemanzyk, Chiara Wirths, Julian Baumeister, Angela Maurer, +7 more
8citations -
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms2023 Research Square preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kristin Holl, Nicolas Chatain, Susanne Krapp, Julian Baumeister, Tiago Maié, Anja Scheufen, +3 more
0citations